Patent ID: 6608032
Filing Date: 2003-08-19
Classification: A61K,A61P,C07H,Y02A,Y10S

Abstract:
A pharmaceutical composition which contains as an active ingredient at least one member selected from the group consisting of:a compound selected from the group consisting of 3,6-anhydrogalactopyranose of formula I: â€ƒan aldehyde and a hydrate thereof, and 2-O-methylated derivatives and 2-O-sulfated derivatives of the 3,6-anhydrogalactopyranose, the aldehyde and the hydrate; and a soluble saccharide that contains said compound at its reducing end, said pharmaceutical composition being used for treating diabetes, rheumatism, a disease that requires inhibition of inflammation for its treatment, a disease that requires inhibition of &agr;-glycosidase for its treatment, a disease that requires inhibition of prostaglandin synthesis for its treatment, a disease that requires inhibition of endotoxin shock for its treatment, a disease that requires inhibition of interleukin production for its treatment, a disease that requires induction of heme oxygenase production for its treatment or prevention, a disease that requires inhibition of tumor necrosis factor production for its treatment, or a disease that requires inhibition of carcinogenesis for its treatment.